lutetium Lu 177-DOTA-di-HSG peptide IMP-288

{
  "id": "MLC-T-ONC-014930",
  "term": "lutetium Lu 177-DOTA-di-HSG peptide IMP-288",
  "field": "Oncology and biomedicine",
  "definition": "A radiolabeled divalent histamine-succinyl-glycine (HSG) hapten-peptide linked with the macrocyclic chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) to the radionuclide lutetium (Lu) 177. After pretargeting with a bispecific monoclonal antibody (BiMoAB) directed against both a tumor associated antigen (TAA) and the HSG hapten-peptide, the HSG portion of administered Lu-177-labeled di-HSG-DOTA peptide IMP-288 binds the anti-HSG portion of the BiMoAB; Lu-177 radioisotopic activity localized to tumor cells bearing the TAA can then be visualized scintigraphically.",
  "synonyms": [
    "Lu-177-labeled di-histamine-succinyl-glycine-DOTA peptide IMP-288"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lutetium-lu-177-dota-di-hsg-peptide-imp-288/"
}